At what pace is the cell line development market growing, and what is its estimated value?
The cell line development market size has grown rapidly in recent years. It will grow from $8.21 billion in 2024 to $9.44 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased vaccine production, increased aging population, and increased clinical trials.
The cell line development market size is expected to see rapid growth in the next few years. It will grow to $16.33 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to increasing prevalence of cancer, increasing prevalence of chronic diseases, increasing government investments in healthcare. Major trends in the forecast period include partnerships, investments, and product innovations.
Get Your Free Sample of The Global Cell Line Development Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15536&type=smp
What are the top drivers to the rising demand in the cell line development market?
An increase in increasing prevalence of cancer is expected to propel the growth of cell line development going forward. Cancer is a term used to describe a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. Cancer has been rising with predominant factors related to population growth and aging, lifestyle choices, obesity, and genetical factor. Cell lines provide a platform for screening potential drug for their efficacy in treating chronic diseases. Researchers are exposed to various compounds and observe their effects, helping them to identify promising drug compounds for further development. For instance, in February 2024, according to the World Health Organization, a Switzerland-based government organization, over 35 million new cancer cases are expected by 2050, a 77% surge from the estimated 20 million cases in 2022. Therefore, an increasing prevalence of cancer drives the cell line development market.
How is the cell line development market segmented?
The cell line development market covered in this report is segmented –
1) By Product: Reagents And Media, Equipment, Accessories And Consumables
2) By Source: Mammalian, Non-Mammalian
3) By Cell Line: Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line
4) By Application: Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research
Subsegments:
1) By Reagents And Media: Cell Culture Media, Serum-Free Media, Recombinant Protein Supplements, Growth Factors, Cytokines And Hormones, Buffers And Salts
2) By Equipment: Bioreactors And Fermenters, Incubators, Cell Counters And Analyzers, Cell Sorters, Cryopreservation Equipment, Filtration And Separation Equipment
3) By Accessories And Consumables: Culture Vessels (Flasks, Plates), Pipettes And Pipette Tips, Cell Culture Inserts, Syringes And Needles, Cryovials And Freezing Containers, Petri Dishes
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/cell-line-development-global-market-report
Who are the top competitors in the cell line development market?
Major companies operating in the cell line development market are Thermo Fisher Scientific Inc., Novartis AG, Danaher Corporation, Merck KGaA, GE Health Care, AGC Biologics, Corning Inc., Eurofins Scientific, Lonza Pvt. Ltd., WuXi App tech, Sartorius AG, GenScript Biotech Corporation, FUJIFILM Diosynth Biotechnologies, Promega corporation, KBI Biopharma Inc., Rentschler Biopharma SE, Advanced Instruments LLC, Cyagen, Horizon Discovery Group Plc, Probiogen AG, PromoCell GmbH, Premas Biotech, Imgenex, NAEJA RGM Pharmaceuticals Inc
What significant trends should we anticipate in the cell line development market over the forecast period?
Major companies operating in the cell line development market are developing innovative platforms to gain a competitive edge in the market. The innovative cell line development platforms stand out for their ability to streamline and optimize the cell line development process, offering speed, efficiency, enhanced productivity to support the development of biological drug. For instance, in January 2023, Abzena, a UK-based that provides outsourced research, development, and manufacturing services launched new platforms called AbZelect and AbZelectPro aimed at accelerating the cell line development (CLD) process for biologic drug programs. These platforms offer higher productivity, enabling the production of more drug substances per manufacturing run. This increased efficiency not only expands capacity and reduces costs for customers but also speeds up the delivery of critical therapies to patients in need.
Which regional trends are influencing the cell line development market, and which area dominates the industry?
North America was the largest region in the cell line development market in 2023. The regions covered in the cell line development market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Cell Line Development Market Report 2025 Offer?
The cell line development market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Cell line development is the process of creating immortalized cell cultures derived from a particular cell type, typically from a specific organism or tissue. These cell lines are cultivated under controlled laboratory conditions and can be perpetually grown and replicated.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15536
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
